Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 13 studies | 27% ± 8% | |
non-classical monocyte | 7 studies | 25% ± 11% | |
alveolar macrophage | 5 studies | 25% ± 2% | |
myeloid cell | 5 studies | 22% ± 4% | |
classical monocyte | 4 studies | 28% ± 7% | |
epithelial cell | 4 studies | 29% ± 13% | |
ciliated cell | 4 studies | 23% ± 5% | |
type I pneumocyte | 4 studies | 22% ± 6% | |
plasma cell | 3 studies | 29% ± 11% | |
microglial cell | 3 studies | 24% ± 4% | |
natural killer cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1681.55 | 1445 / 1445 | 100% | 63.02 | 183 / 183 |
ovary | 100% | 1958.90 | 180 / 180 | 100% | 91.48 | 430 / 430 |
pancreas | 100% | 1315.24 | 328 / 328 | 100% | 86.24 | 178 / 178 |
uterus | 100% | 1919.64 | 170 / 170 | 100% | 89.85 | 459 / 459 |
lung | 100% | 2523.88 | 578 / 578 | 100% | 94.37 | 1154 / 1155 |
thymus | 100% | 2542.90 | 653 / 653 | 100% | 117.62 | 604 / 605 |
kidney | 100% | 1470.72 | 89 / 89 | 100% | 91.23 | 899 / 901 |
breast | 100% | 2017.70 | 459 / 459 | 100% | 122.88 | 1115 / 1118 |
skin | 100% | 2435.79 | 1809 / 1809 | 99% | 108.70 | 469 / 472 |
intestine | 100% | 1990.51 | 966 / 966 | 99% | 65.81 | 523 / 527 |
prostate | 100% | 1889.66 | 245 / 245 | 99% | 70.35 | 498 / 502 |
stomach | 100% | 1902.70 | 359 / 359 | 99% | 65.67 | 283 / 286 |
bladder | 100% | 1976.24 | 21 / 21 | 99% | 82.28 | 497 / 504 |
adrenal gland | 100% | 2166.40 | 258 / 258 | 97% | 61.50 | 223 / 230 |
brain | 97% | 905.49 | 2560 / 2642 | 100% | 80.82 | 705 / 705 |
liver | 99% | 1291.52 | 223 / 226 | 97% | 66.95 | 392 / 406 |
adipose | 100% | 2036.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2664.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 148.64 | 29 / 29 |
spleen | 100% | 2172.62 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 102.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.14 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 72.36 | 79 / 80 |
peripheral blood | 99% | 1805.62 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 1154.62 | 837 / 861 | 0% | 0 | 0 / 0 |
muscle | 92% | 872.31 | 741 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043353 | Biological process | enucleate erythrocyte differentiation |
GO_0006309 | Biological process | apoptotic DNA fragmentation |
GO_0006259 | Biological process | DNA metabolic process |
GO_0050776 | Biological process | regulation of immune response |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0003677 | Molecular function | DNA binding |
GO_0004531 | Molecular function | deoxyribonuclease II activity |
Gene name | DNASE2 |
Protein name | Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (Lysosomal DNase II) Deoxyribonuclease II Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (DNase II alpha) (Lysosomal DNase II) (R31240_2) |
Synonyms | DNL2 DNASE2A |
Description | FUNCTION: Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the clearance of nucleic acids generated through apoptosis, hence preventing autoinflammation . Necessary for proper fetal development and for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells . . FUNCTION: Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the clearance of nucleic acids generated through apoptosis, hence preventing autoinflammation. Necessary for proper fetal development and for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells. . FUNCTION: Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the clearance of nucleic acids generated through apoptosis, hence preventing autoinflammation. Necessary for proper fetal development and for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells. . |
Accessions | K7ENE5 Q9H3R9 Q96TC5 O00115 ENST00000698693.1 ENST00000592506.2 [O00115-2] ENST00000222219.8 [O00115-1] ENST00000592506.1 A0A8V8TNK3 |